Work

Supplementary Figure 4 from A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity

Year: 2023
Type: supplementary-materials
Abstract: GS87 does not lead to observable alterations in normal hematopoiesis
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362494019
Cites:
Cited by:
Related to: 10